ArticleMMWR. Morbidity and mortality weekly report2023

Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023.

Ruth Link-Gelles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.